Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01HL042799-07
Application #
2220678
Study Section
Clinical Trials Review Committee (CLTR)
Project Start
1989-08-01
Project End
1997-07-31
Budget Start
1995-08-01
Budget End
1997-07-31
Support Year
7
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Puget Sound Blood Center
Department
Type
DUNS #
City
Seattle
State
WA
Country
United States
Zip Code
98104
Jackman, Rachael P; Deng, Xutao; Bolgiano, Douglas et al. (2013) Low-level HLA antibodies do not predict platelet transfusion failure in TRAP study participants. Blood 121:3261-6; quiz 3299
Slichter, Sherrill J; Bolgiano, Douglas; Kao, Kuo-Jang et al. (2011) Persistence of lymphocytotoxic antibodies in patients in the trial to reduce alloimmunization to platelets: implications for using modified blood products. Transfus Med Rev 25:102-10
Slichter, Sherrill J; Davis, Kathryn; Enright, Helen et al. (2005) Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients. Blood 105:4106-14
Enright, Helen; Davis, Kathryn; Gernsheimer, Terry et al. (2003) Factors influencing moderate to severe reactions to PLT transfusions: experience of the TRAP multicenter clinical trial. Transfusion 43:1545-52
Davis, K B; Slichter, S J; Corash, L (1999) Corrected count increment and percent platelet recovery as measures of posttransfusion platelet response: problems and a solution. Transfusion 39:586-92
(1997) Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. The Trial to Reduce Alloimmunization to Platelets Study Group. N Engl J Med 337:1861-9
Kao, K J; Mickel, M; Braine, H G et al. (1995) White cell reduction in platelet concentrates and packed red cells by filtration: a multicenter clinical trial. The Trap Study Group. Transfusion 35:13-9